Jurczak, W., Kwiatek, M., Czyz, J., Mattos, E. D., Eom, K., Egle, A., Panovská, A., Grudeva-Popova, Z., Shih, H., Montero, L. F. C., Sportoletti, P., Hua, V. M., D'Olimpio, J., Iida, S., Ito, R., Bao, K., Fink, A., Su, W., Stark, A. R., Levy, A., Wróbel, T. (2025). Pirtobrutinib vs bendamustine plus rituximab (BR) in patients with CLL/SLL: First results from a randomized phase III study Examining a non-covalent BTK inhibitor in untreated patients. Blood. https://doi.org/10.1182/blood-2025-lba-3